Tregalizumab (Anti-CD4)
Tregalizumab (Anti-CD4) is a humanized anti-human CD4 monoclonal antibody (IgG1 type) that selectively activates the suppressive properties of regulatory T cells (Tregs). Tregalizumab can be used in the research of autoimmune diseases. MW : 147.42 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2820 |
| Sku # | A2820-1mg*25 |
| Pricing | 1mg*25, $4170.00 |